Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page footer revision marker was updated to **Revision: v3.5.3** (from **v3.5.2**), reflecting an interface/version change rather than any study-record information.
    Difference
    0.0%
    Check dated 2026-04-25T17:47:34.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:15:05.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-20T13:31:11.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T04:02:06.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; prior notice about government funding status (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T16:21:45.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and NIH Clinical Center operations was added, and the page now shows a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:45:23.000Z thumbnail image

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.